Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Woolworths | Sydney | Consumer Non-Cyclicals | Food & Drug Retailing | A$39.35B | 24.1x | 0 | A$32.24 | 0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 1.2% Upside | Upgrade to Pro+ | |
Coles Group | Sydney | Consumer Non-Cyclicals | Food & Drug Retailing | A$28.20B | 25.3x | 4.33 | A$21.10 | 0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 3.8% Upside | Upgrade to Pro+ | |
Endeavour Group | Sydney | Consumer Non-Cyclicals | Food & Drug Retailing | A$7.41B | 16.2x | -1.48 | A$4.18 | 0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 8.7% Upside | Upgrade to Pro+ | |
Metcash | Sydney | Consumer Non-Cyclicals | Food & Drug Retailing | A$4.46B | 15.7x | 40.5 | A$4.07 | 0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 2.8% Upside | Upgrade to Pro+ | |
Jatcorp | Sydney | Consumer Non-Cyclicals | Food & Drug Retailing | A$27.06M | 75.6x | 0.72 | A$0.32 | -4.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Aumake | Sydney | Consumer Non-Cyclicals | Food & Drug Retailing | A$9.07M | -0.8x | 0.02 | A$0.003 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |